نتایج جستجو برای: neonatal abstinence syndrome
تعداد نتایج: 701339 فیلتر نتایج به سال:
Neonatal abstinence syndrome (NAS) is experienced by newborn infants who have been exposed to opioids in utero. It is the subject of intensive study and, in 2013 alone, just over 70 new papers on the topic appeared in PubMed. Clinical assessment is carried out using a special scoring system which has become internationally established, and the Finnegan score or other modified scores frequently ...
Oxcarbazepine is a second-generation antiepileptic drug that is used to treat partial seizures. Although it has been increasingly used in pregnant women, its fetal safety has not been fully validated. We describe a 12-hour-old neonate who developed neonatal abstinence syndrome (NAS) after intrauterine exposure to oxcarbazepine. The neonate was born via cesarean section to a mother who took oxca...
Neonatal abstinence syndrome (NAS) is a drug withdrawal syndrome that most commonly occurs in infants after in utero exposure to opioids, although other substances have also been associated with the syndrome (1). NAS usually appears within 48-72 hours of birth with a constellation of clinical signs, including central nervous system irritability (e.g., tremors), gastrointestinal dysfunction (e.g...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید